About the Authors

Stuart Aitken

Stuart.Aitken@igmm.ed.ac.uk

Affiliation MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom

Shigeyuki Magi

Affiliation Laboratory for Integrated Cellular Systems, RIKEN Center for Integrative Medical Sciences, IMS, W518, Suehiro-cho, Tsurumi-ku, Yokohama, Japan

Ahmad M. N. Alhendi

Affiliation UNSW Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia

Masayoshi Itoh

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Saitama, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Hideya Kawaji

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Saitama, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Timo Lassmann

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Carsten O. Daub

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Erik Arner

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Piero Carninci

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Alistair R. R. Forrest

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Yoshihide Hayashizaki

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Saitama, Japan

the FANTOM Consortium

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan

Levon M. Khachigian

Affiliation UNSW Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia

Mariko Okada-Hatakeyama

Affiliation Laboratory for Integrated Cellular Systems, RIKEN Center for Integrative Medical Sciences, IMS, W518, Suehiro-cho, Tsurumi-ku, Yokohama, Japan

Colin A. Semple

Affiliation MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: MOH SM AMNA LMK. Performed the experiments: SM AMNA. Analyzed the data: SA. Wrote the paper: SA CAS. Contributed to the manuscript: SM MOH EA AMNA LMK. Managed The FANTOM5 project: COD ARRF PC YH. Prepared CAGE libraries: MI. Pre-processed CAGE data: HK TL. Performed quality control of the CAGE data: EA.